Shifting the balance of brain tryptophan metabolism elicited by isolation housing and systemic administration of lipopolysaccharide in mice

Stress

Volumn 12, Issue 3, 2009, Pages 206-214

  Miura, Hideki ^a   Shirokawa, Tetsuya ^b   Isobe, Kenichi ^a   Ozaki, Norio ^a  

^a NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b NIHON FUKUSHI UNIVERSITY   (Japan)

Author keywords

Depression; Immune stress; Kynurenine; Serotonin; Social isolation; Tryptophan

Indexed keywords

BACTERIUM LIPOPOLYSACCHARIDE; KYNURENINE; SEROTONIN; TRYPTOPHAN; LIPOPOLYSACCHARIDE;

AMYGDALOID NUCLEUS; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN; DEPRESSION; DORSAL RAPHE NUCLEUS; ENVIRONMENTAL FACTOR; HIPPOCAMPUS; INFLAMMATION; MALE; METABOLIC BALANCE; MOUSE; NONHUMAN; PREFRONTAL CORTEX; PRIORITY JOURNAL; RISK FACTOR; SEROTONINERGIC SYSTEM; SOCIAL ISOLATION; TRYPTOPHAN BRAIN LEVEL; TRYPTOPHAN METABOLISM; ANIMAL; ANIMAL HOUSING; DRUG EFFECT; INSTITUTE FOR CANCER RESEARCH MOUSE; METABOLISM; RAPHE NUCLEUS;

AMYGDALA; ANIMALS; BRAIN; HIPPOCAMPUS; HOUSING, ANIMAL; KYNURENINE; LIPOPOLYSACCHARIDES; MALE; MICE; MICE, INBRED ICR; PREFRONTAL CORTEX; RAPHE NUCLEI; SEROTONIN; SOCIAL ISOLATION; TRYPTOPHAN;

EID: 67949088310     PISSN: 10253890     EISSN: 16078888     Source Type: Journal    
DOI: 10.1080/10253890802252442     Document Type: Article

References (59)

1. Bonaccorso S, Marino V, Puzella A, Pasquini M, Biondi M, Artini M, Almerighi C, Verkerk R, Meltzer H, Maes M. 2002. Increased depressive ratings in patients with hepatitis C receiving interferon-alpha-based immunotherapy are related to interferon-alpha-induced changes in the serotonergic system. J Clin Psychopharmacol 22:86-90
2. Capuron L, Ravaud A, Neveu PJ, Miller AH, Maes M, Dantzer R. 2002. Association between decreased serum tryptophan concentrations and depressive symptoms in cancer patients undergoing cytokine therapy. Mol Psychiatry 7:468-473
3. Capuron L, Neurauter G, Musselman DL, Lawson DH, Nemeroff CB, Fuchs D, Miller AH. 2003. Interferon-alpha-induced changes in tryptophan metabolism. relationship to depression and paroxetine treatment. Biol Psychiatry 54:906-914
4. Chaouloff F. 1997. Effects of acute physical exercise on central serotonergic systems. Med Sci Sports Exerc 29:58-62
5. Cooper JR, Bloom FE, Roth RH. 2003. Serotonin (5-hydroxytryp-tamine), histamine, and adenosine. In: The biochemical basis of neuropharmacology. New York: Oxford University Press. p 271-320
6. Curzon G, Friedel J, Knott PJ. 1973. The effect of fatty acids on the binding of tryptophan to plasma protein. Nature 242:198-200
7. Delgado PL. 2004. How antidepressants help depression: Mechanisms of action and clinical response. J Clin Psychiatry 65(Suppl 4):25-30
8. Dunn AJ. 1988. Systemic interleukin-1 administration stimulates hypothalamic norepinephrine metabolism paralleling the increased plasma corticosterone. Life Sci 43:429-435
9. Dunn AJ. 1992. Endotoxin-induced activation of cerebral catechol-amine and serotonin metabolism: Comparison with interleukin-1. J Pharmacol Exp Ther 261:964-969
10. Dunn AJ. 2006. Effects of cytokines and infections on brain neurochemistry. Clin Neurosci Res 6:52-68
11. Dunn AJ, Welch J. 1991. Stress- and endotoxin-induced increases in brain tryptophan and serotonin metabolism depend on sympathetic nervous system activity. J Neurochem 57:1615-1622
12. Fernstrom JD, Wurtman RJ. 1972. Brain serotonin content: Physiological regulation by plasma neutral amino acids. Science 178:414-416
13. Fukui S, Schwarcz R, Rapoport SI, Takada Y, Smith QR. 1991. Blood-brain barrier transport of kynurenines: Implications for brain synthesis and metabolism. J Neurochem 56:2007-2015
14. Gal EM, Sherman AD. 1980. 1-Kynurenine: Its synthesis and possible regulatory function in brain. Neurochem Res 5:223-239
15. Heyes MP, Quearry BJ, Markey SP. 1989. Systemic endotoxin increases L-tryptophan, 5-hydroxyindoleacetic acid, 3-hydro-xykynurenine and quinolinic acid content of mouse cerebral cortex. Brain Res 491:173-179
16. Heyes MP, Saito K,Chen CY, Proescholdt MG, Nowak TS, Jr.,Li J, Beagles KE, Proescholdt MA, Zito MA, Kawai K, Markey SP. 1997. Species heterogeneity between gerbils and rats: Quinoli-nate production by microglia and astrocytes and accumulations in response to ischemic brain injury and systemic immune activation. J Neurochem 69:1519-1529
17. Kabiersch A, del Rey A, Honegger CG, Besedovsky HO. 1988. Interleukin-1 induces changes in norepinephrine metabolism in the rat brain. Brain Behav Immun 2:267-274
18. Kendler KS, Kessler RC, Neale MC, Heath AC, Eaves LJ. 1993. The prediction of major depression in women: Toward an integrated etiologic model. Am J Psychiatry 150:1139-1148
19. Kita T, Morrison PF, Heyes MP, Markey SP. 2002. Effects of systemic and central nervous system localized inflammation on the contributions of metabolic precursors to the L-kynurenine and quinolinic acid pools in brain. J Neurochem 82:258-268
20. Konsman JP, Parnet P, Dantzer R. 2002. Cytokine-induced sickness behaviour: Mechanisms and implications. Trends Neurosci 25:154-159
21. Laich A, Neurauter G, Widner B, Fuchs D. 2002. More rapid method for simultaneous measurement at tryptophan and kynurenine by HPLC. Clin. Chem. 48:579-581
22. Linthorst ACE, Flachskamm C, Holsbboer F, Reul JMHM. 1996. Activation of serotonergic and noradrenergic neurotransmission in the rat hippocampus after peripheral administration of bacterial endotoxin: Involvement of the cyclo-oxygenase pathway. Neuroscience 72:989-997
23. Maes M, Meltzer HY, Scharpe S, Bosmans E, Suy E, De Meester I, Calabrese J, Cosyns 7P. 1993. Relationships between lower plasma L-tryptophan levels and immune-inflammatory variables in depression. Psychiatry Res 49:151-165
24. Maes M, Scharpe S,Meltzer HY, Okayli G,Bosmans E, DHondt P, Vanden Bossche BV, Cosyns P. 1994. Increased neopterin and interferon-gamma secretion and lower availability of L-trypto-phan in major depression: Further evidence for an immune response. Psychhiatry Res 54:143-160
25. Maes M, Smith R, Scharpe S. 1995. The monocyte-T-lymphocyte hypothesis of major depression. Psychoneuroendocrinology 20:111-116
26. Maes M, Wauters A, Verkerk R, Demedts P, Neels H, Van Gastel A, Cosyns P, Scharpe S, Desnyder R. 1996. Lower serum L-tryptophan availability in depression as a marker of a more generalized disorder in protein metabolism. Neuropsychophar-macology 15:243-251
27. Maes M, Song C, Lin A, De Jongh R, Van Gastel A, Kenis G, Bosmans E, De Meester I, Benoy I, Neels H, Demedts P, Janca A, Scharpe S, Smith RS. 1998. The effects of psychological stress on humans: Increased production of pro-inflammatory cytokines and a Th1-like response in stress-induced anxiety. Cytokine 10:313-318
28. McMenamy RH. 1965. Binding of indole analogues to human serum albumin. Effects of fatty acids. J Biol Chem 240:4235-4243
29. Minami M, Kuraishi Y, Yamaguchi T, Nakai S, Hirai Y, Satoh M. 1991. Immobilization stress induces interleukin-1 beta mRNA in the rat hypothalamus. Neurosci Lett 123:254-256
30. Miura H, Qiao H, Ohta T. 2002a. Influence of aging and social isolation on changes in brain monoamine turnover and biosynthesis of rats elicited by novelty stress. Synapse 46:116-124
31. Miura H, Qiao H, Ohta T. 2002b. Attenuating effects of the isolated rearing condition on increased brain serotonin and dopamine turnover elicited by novelty stress. Brain Res 926:10-17
32. Miura H, Qiao H, Kitagami T, Ohta T. 2004. Fluvoxamine, a selective serotonin reuptake inhibitor, suppresses tetrahydro-biopterin in the mouse hippocampus. Neuropharmacology 46:340-348
33. Miura H, Qiao H, Kitagami T, Ohta T, Ozaki N. 2005a. Effects of fluvoxamine on levels of dopamine, serotonin, and their metabolites in the hippocampus elicited by isolation housing and novelty stress in adult rats. Int J Neurosci 115:367-378
34. Miura H, Qiao H, Kitagami T, Ohta T, Ozaki N. 2005b. Fluvoxamine, a selective serotonin reuptake inhibitor, suppresses tetrahydrobiopterin levels and dopamine as well as serotonin turnover in the mesoprefrontal system of mice. Psychopharmacology (Berl) 177:307-314
35. Miura H, Kitagami T, Ozaki N. 2007. Suppressive effect of paroxetine, a selective serotonin uptake inhibitor, on tetrahy-drobiopterin levels and dopamine as well as serotonin turnover in the mesoprefrontal system of mice. Synapse 61:698-706
36. Miura H, Ozaki N, Shirokawa T, Isobe K. 2008a. Changes in brain tryptophan metabolism elicited by aging, social environment, and psychological stress in mice. Stress 11(2):160-169
37. Miura H, Ozaki N, Sawada M, Isobe K, Ohta T, Nagatsu T. 2008b. A link between stress and depression: Shifts in the balance between the kynurenine and serotonin pathways of tryptophan metabolism and the etiology and pathophysiology of depression. Stress 11(3):198-209
38. Moffett JR, Namboodiri MA. 2003. Tryptophan and the immune response. Immunol Cell Biol 81:247-265
39. Molina-Holgado F, Guaza C. 1996. Endotoxin administration induced differential neurochemical activation of the rat brain stem nuclei. Brain Res Bull 40:151-156
40. Moroni F, Russi P, Gallo-Mezo MA, Moneti G, Pellicciari R. 1991. Modulation of quinolinic and kynurenic acid content in the rat brain: Effects of endotoxins and nicotinylalanine. J Neurochem 57:1630-1635
41. Muller N, Schwarz MJ. 2007. The immune-mediated alteration of serotonin and glutamate: Towards an integrated view of depression. Mol Psychiatry 12:988-1000
42. Myint AM, Kim YK. 2003. Cytokine-serotonin interaction through IDO: A neurodegeneration hypothesis of depression. Med Hypotheses 61:519-525
43. NguyenKT,DeakT,OwensSM,KohnoT,FleshnerM,WatkinsLR, Maier SF. 1998. Exposure to acute stress induces brain interleukin-1beta protein in the rat. J Neurosci 18:2239-2246
44. Nolan Y, Connor TJ, Kelly JP, Leonard BE. 2000. Lipopolysac-charide administration produces time-dependent and region-specific alterations in tryptophan and tyrosine hydroxylase activities in rat brain. J Neural Transm 107:1393-1401
45. Owens MJ. 2004. Selectivity of antidepressants: From the monoamine hypothesis of depression to the SSRI revolution and beyond. J Clin Psychiatry 65(Suppl 4):5-10
46. Paykel ES. 1994. Life events, social support and depression. Acta Psychiatr Scand Suppl 377:50-58
47. Saito K, Markey SP, Heyes MP. 1992. Effects of immune activation on quinolinic acid and neuroactive kynurenines in the mouse. Neuroscience 51:25-39
48. Schrocksnadel K, Wirleitner B, Winkler C, Fuchs D. 2006. Monitoring tryptophan metabolism in chronic immune activation. Clin Chim Acta 364:82-90
49. Schule C. 2007. Neuroendocrinological mechanisms of actions of antidepressant drugs. J Neuroendocrinol 19:213-226
50. Schulte HM, Bamberger CM, Elsen H, Herrmann G, Bamberger AM, Barth J. 1994. Systemic interleukin-1 alpha and interleukin-2 secretion in response to acute stress and to corticotropin-releasing hormone in humans. Eur J Clin Invest 24:773-777
51. Shimizu T, Nomiyama S, Hirata F, Hayashi O. 1978. Indoleamine 2,3-dioygenase. Purification and some properties. J Biol Chem 263:4700-4706
52. ShintaniF,NakakiT, KanbaS, SatoK, Yagi G, Shiozawa M,Aiso S, Kato R, Asai M. 1995. Involvement of interleukin-1 in immobilization stress-induced increase in plasma adrenocortico-tropic hormone and in release of hypothalamic monoamines in the rat. J Neurosci 15:1961-1970
53. Smith RS. 1991. The macrophage theory of depression. Med Hypotheses 35:298-306
54. Stone TW, Darlington LG. 2002. Endogenous kynurenines as targets for drug discovery and development. Nat Rev Drug Discov 1:609-620
55. Struder HK, Hollmann W, Platen P, Wostmann R, Weicker H, Molderings GJ. 1999. Effect of acute and chronic exercise on plasma amino acids and prolactin concentrations and on [3H]ketanserin binding to serotonin2A receptors on human platelets. Eur J Appl Physiol Occup Physiol 79:318-324
56. Van der Does AJ. 2001. The effects of tryptophan depletion on mood and psychiatric symptoms. J Affect Disord 64:107-119
57. Wichers MC, Maes M. 2004. The role of indoleamine 2,3-dioxygenase (IDO) in the pathophysiology of interferon-alpha-induced depression. J Psychiatry Neurosci 29:11-17
58. Widner B, Werner ER, Schennach H, Watcher H, Fuchs D. 1997. Simultaneous measurement of serum tryptophan and kynur-enine by HPLC. Clin. Chem. 43:2424-2426
59. Widner B, Laich A, Sperner-Unterweger B, Ledochowski M, Fuchs D. 2002. Neopterin production, tryptophan degradation, and mental depression - what is the link? Brain Behav Immun 16:590-595 (Pubitemid 35333739)